Products List 0
Precision Cre Recombinase, Tat-NLS-Cre, TAT-Cre, HTNC, HTNCre
Cre Recombinase Exosome Like Vesicles
NLS-Flp Recombinase Virus-like Particles, VSVG pseudotyped
Cre Recombinase, Tat-NLS-Cre, TAT-Cre, HTNC, HTNCre, endotoxin-free
FLP Recombinase, Tat-NLS-Flp, TAT-Flp, HTNFlp
GRGreen DNA Loading Buffer
Terminal deoxynucleotidyl Transferase (TdT)
Ultrapure E. coli DNA Ligase
Recombinant Trigger Factor, tig
Turbo Enterokinase Protease
Custom assembly of TAL effector repeat array (transcription activator–like effector nuclease, TALEN and TALE transcription factor, TALE-TF)
Codon-optimized Cre Recombinase, Non-Integrative Lentivirus
Turbo Human Rhinovirus 3C (HRV 3C) Protease, His-HRV 3C
Turbo His-MBP-TEV Protease
GRRed DNA Loading Buffer
Gel Documentation System for Safe Nucleic Acid Stains, GRGreen, GelStar, GelGreen, SYBR Gold and SYBR Safe
Fast Electrophoresis Buffer, 20X
GRGreen Nucleic Acid Stain, 10,000X in Water
5' Anti-Reverse Cap Analog (ARCA) capped FLuc mRNA
5' Anti-Reverse Cap Analog (ARCA) capped GFP mRNA
5' Anti-Reverse Cap Analog (ARCA) capped FLP recombinase mRNA, NLS-hFLP
Ultrapure Fast T3 DNA Ligase
Ultrapure Rapid T7 DNA Ligase
Ultrapure Fast T4 DNA Ligase
HTN-GFP, Cell-Permeable Green Fluorescent Protein
NLS-Cre Recombinase Virus-like Particles, AAV pseudotyped
MembraneExpressTM Functional Membrane Protein Virus-like Particles
NLS-Cre Recombinase Virus-like Particles, VSVG pseudotyped
5' Anti-Reverse Cap Analog (ARCA) capped Cre recombinase mRNA, NLS-Cre
Turbo Human Rhinovirus 3C (HRV 3C) Protease, His-GST-HRV 3C
Thermostable Taq DNA Ligase
Ultrapure Fast T7 DNA Ligase
Cre Recombinase, HNC
Cre Recombinase, MPGa-NLS-Cre
Cre Recombinase, Penetratin-Cre
Cre Recombinase, VPMLK-TAT-NLS-Cre
Cre Recombinase, KLPVM-NLS-Cre
Cre Recombinase, VPMLK-NLS-Cre
Cre Recombinase, VPTLK-NLS-Cre
Synthesis of Capped mRNA
Liver-X Receptor alpha isoform
Farnesoid-X-activated Receptor
Retinoid X Receptor-alpha Ligand Binding Domain
Thyroid Hormone Receptor beta 1 isoform
Retinoid X Receptor alpha
PCAF (p300/CBP Associated Factor)
Cyclophilin A
p300-Ch1
p300 (Tumor Suppressor Protein and Transcription Factor)
HDAC3 (Histone Deacetylase)
SRC1-RID (No-tag)
SRC1-RID (His/TEV)
SRC1-RID Biotinylated / His Tag removed
SRC1-RID His Tagged
SRC1-RID [627-786] Biotinylated / His Tagged
p75-CTR [C-terminal region of p75 (LEDGF)]
PC4-mt (serine mutations)
PC4-mt (Positive Cofactor 4 F77P mutant)
p52 (PC4 and SFRS1 interacting protein 1)
PC4 (Positive Cofactor 4 wild type) Transcriptional Coactivator
CSK (c-src Tyrosine Kinase)
Mitogen-Activated Protein Kinase 1(ERK2)
TNF-alpha (Low Endotoxin)
Nrf2, NFE2L2, nuclear factor erythroid 2-related factor 2
MAX (Myc-Associated Factor X)
MAD (MAX dimerization protein 1, MXD1)
HIF-1a NTAD (Hypoxia-Inducible Factor 1 alpha N-Terminal Activation Domain (530-698)
HIF-1a CTAD (Hypoxia-Inducible Factor 1 alpha C-Terminal Activation Domain)
MDM2 (Mouse double minute 2) Human Oncoprotein
FRA-1 (Fos-related antigen 1)
SV40 T-Antigen (Simian Virus 40 Large Antigen)
FGF-2 (Low Molecular Weight, 134-278)
FGF-1 (acidic fibroblast growth factor)
RAD51
BCL-10 (B Cell Lymphoma 10)
Wilm’s Tumor Suppressor 1 (-KTS)
BRCA1 (Tumor Suppressor Protein and Transcription Factor)
Thermostable M-MuLV Reverse Transcriptase
Turbo His-GST-TEV Protease
Endofree Plasmid MaxiPrep
Ultrapure Taq DNA Polymerase
c-jun (proto oncogene)
293Expresso™ Transfection Reagent
c-myc (proto oncogene)
VHL (von Hippel-Lindau tumor suppressor protein)
Wilm’s Tumor Suppressor 1 (+KTS)
pRB (Retinoblastoma protein)
3C HiFi DNA Polymerase
FastÄQ™ Low ROX™ One-Step SYBR Green qRT-PCR Kit
FastÄQ™ One-Step SYBR Green qRT-PCR Kit, ROX™
FastÄQ™ One-Step SYBR Green qRT-PCR Kit
50xHiFi DNA Polymerase
FastÄQTM Taq DNA Polymerase
ÄQStartTM Taq Mastermix
ÄQStartTM Taq DNA polymerase
HiFiÄQStartTM Taq Mastermix
HiFiÄQStartTM Taq DNA Polymerase
Recombinant Thermus aquaticus Muts Protein (MBP-Muts fusion protein)
Lin28 Virus-like Particles
NANOG Virus-like Particles
C-Fos (proto oncogene)
p53 [1-342] C-terminal deletion, recombinant protein
p53 [1-363] C-terminal deletion, recombinant protein
p53, Recombinant wild-type human p53 protein
5'-Capped human Klf4-Oct4-Sox2-c-Myc (KOSM) mRNA cocktail for generating induced pluripotent stem cells (iPSC)
Recombinant Thioredoxin Protein
Recombinant NusA Protein
Maltose Binding Protein, MBP
Sox2 Virus-like Particles
c-Myc Virus-like Particles
Recombinant Glutathione S-transferase, GST
Gene Synthesis and Custom Cloning
Mouse Klf4-Oct4-Sox2-c-Myc (KOSM) Non-Integrative Lentivirus
Oct-3/4 Virus-like Particles
Klf4 Virus-like Particles
Turbo TEV protease
Cre Recombinase, Tat-NLS-Cre, TAT-Cre, HTNC, HTNCre
CK2, human, alpha subunit, (Human casein kinase 2, alpha subunit (hCK2 alpha))
v-raf murine sarcoma 3611 viral oncogene homolog 1, ARAF1
phosphomevalonate kinase, PMVK
non-metastatic cells 4, protein expressed in, NME4
insulin-like growth factor 1 receptor, IGF1R
guanylate kinase 1, GUK1
Mst3 and SOK1-related kinase, MST4
phosphorylase kinase, gamma 1 (muscle), PHKG1
hypothetical protein FLJ10074, FLJ10074
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3, PFKFB3
PFTAIRE protein kinase 1, PFTK1
phosphoglycerate kinase 1, PGK1
serine/threonine kinase 22B (spermiogenesis associated), STK22B
protein kinase, AMP-activated, alpha 2 catalytic subunit, PRKAA2
protein kinase, cAMP-dependent, catalytic, alpha, PRKACA
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian), EGFR
hypothetical protein LOC340371, LOC340371
protein kinase, cAMP-dependent, catalytic, beta, PRKACB
hypothetical protein BC007901, LOC91461
CDC-like kinase 1, CLK1
fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome), FGFR1
mitogen-activated protein kinase 6, MAPK6
platelet-derived growth factor receptor, beta polypeptide, PDGFRB
TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal), TEK
MAP/microtubule affinity-regulating kinase 3, MARK3
hemopoietic cell kinase, HCK
mitogen-activated protein kinase 1, MAPK1
phosphoenolpyruvate carboxykinase 1 (soluble), PCK1
EphA2, EPHA2
calcium/calmodulin-dependent protein kinase kinase 2, beta, CAMKK2
protein kinase, cAMP-dependent, catalytic, gamma, PRKACG
phosphoinositide-3-kinase, catalytic, gamma polypeptide, PIK3CG
tyrosine kinase with immunoglobulin and epidermal growth factor homology domains, TIE
thioredoxin domain containing 3 (spermatozoa), TXNDC3
protein kinase C-like 1, PRKCL1
adrenergic, beta, receptor kinase 1, ADRBK1
tousled-like kinase 1, TLK1
hypothetical protein MGC45428, MGC45428
elongation factor-2 kinase, EEF2K
testis-specific kinase 1, TESK1
Similar to calcium/calmodulin-dependent protein kinase 1, beta, PNCK
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2), MPP2
PTEN induced putative kinase 1, PINK1
aarF domain containing kinase 4, FLJ12229
calcium/calmodulin-dependent protein kinase kinase 1, alpha, CAMKK1
feline sarcoma oncogene, FES
hypothetical protein FLJ34389, FLJ34389
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4, DYRK4
mitogen-activated protein kinase kinase kinase kinase 5, MAP4K5
casein kinase 1, alpha 1-like, MGC33182
serine/threonine kinase 36 (fused homolog, Drosophila), STK36
hypothetical protein MGC26597, MGC26597
transcriptional intermediary factor 1, TIF1
protein kinase C, eta, PRKCH
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma, CAMK2G
inositol 1,4,5-trisphosphate 3-kinase A, ITPKA
BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast), BUB1B
mitogen-activated protein kinase 12, MAPK12
casein kinase 1, delta, CSNK1D
tyrosine kinase 2, TYK2
3-phosphoinositide dependent protein kinase-1, PDPK1
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian), SRC
fibroblast growth factor receptor 4, FGFR4
adenylate kinase 2, AK2
v-raf-1 murine leukemia viral oncogene homolog 1, RAF1
casein kinase 1, epsilon, CSNK1E
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian), EGFR
CHK1 checkpoint homolog (S. pombe), CHEK1
v-akt murine thymoma viral oncogene homolog 1, AKT1
cyclin-dependent kinase 2, CDK2
protein serine kinase H1, PSKH1
protein kinase Njmu-R1, NJMU-R1
phosphoglycerate kinase 2, PGK2
serine/threonine kinase 38 like, STK38L
serine/threonine kinase 22C (spermiogenesis associated), STK22C
serine/threonine kinase 32A, MGC22688
extracellular signal-regulated kinase 8, ERK8
hypothetical protein MGC42105, MGC42105
NIMA (never in mitosis gene a)-related kinase 7, NEK7
serine/threonine kinase 29, STK29
Human polo-like kinase 2, SNK
creatine kinase, brain, CKB
tribbles homolog 3 (Drosophila), C20orf97
cell division cycle 2, G1 to S and G2 to M, CDC2
guanylate kinase 1, GUK1
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase), NME7
creatine kinase, muscle, CKM
adenylate kinase 1, AK1
sphingosine kinase 1, SPHK1
serine/threonine kinase 11 (Peutz-Jeghers syndrome), STK11
branched chain alpha-ketoacid dehydrogenase kinase, BCKDK
pyruvate kinase, muscle, PKM2
mitogen-activated protein kinase-activated protein kinase 3, MAPKAPK3
phosphofructokinase, liver, PFKL
thymidine kinase 1, soluble, TK1
mitogen-activated protein kinase kinase 5, MAP2K5
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha, PIP5K1A
sphingosine kinase 2, SPHK2
RIO kinase 1 (yeast), AD034
phosphomevalonate kinase, PMVK
serine/threonine kinase 6, STK6
aurora kinase B, STK12
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2, DYRK2
receptor-interacting serine-threonine kinase 2, RIPK2
ribosomal protein S6 kinase-like 1, RPS6KL1
serine/threonine kinase 24 (STE20 homolog, yeast), STK24
ketohexokinase (fructokinase), KHK
pyruvate dehydrogenase kinase, isoenzyme 2, PDK2
cyclin-dependent kinase 4, CDK4
NIMA (never in mitosis gene a)-related kinase 6, NEK6
hypothetical protein MGC8407, MGC8407
calmodulin 2 (phosphorylase kinase, delta), CALM2
creatine kinase, mitochondrial 1 (ubiquitous), CKMT1
hexokinase 1, HK1
oxidative-stress responsive 1, OSR1
MAP/microtubule affinity-regulating kinase 2, MARK2
heme-regulated initiation factor 2-alpha kinase, HRI
protein kinase C, zeta, PRKCZ
mitogen-activated protein kinase 13, MAPK13
discoidin domain receptor family, member 1, DDR1
non-metastatic cells 4, protein expressed in, NME4
ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease), RET
STE20-like kinase, JIK
mitogen-activated protein kinase 3, MAPK3
mitogen-activated protein kinase 6, MAPK6
mitogen-activated protein kinase 8, MAPK8
tribbles homolog 2 (Drosophila), GS3955
heat shock 22kDa protein 8, H11
deoxythymidylate kinase (thymidylate kinase), DTYMK
CHK2 checkpoint homolog (S. pombe), CHEK2
CHK1 checkpoint homolog (S. pombe), CHEK1
phosphatidylinositol 4-kinase type II, PI4KII
Human polo-like kinase 1, PLK
hemopoietic cell kinase, HCK
casein kinase 1, delta, CSNK1D
adenosine kinase, ADK
protein kinase C, delta, PRKCD
protein kinase C, iota, PRKCI
phosphoribosyl pyrophosphate synthetase 1, PRPS1
cyclin-dependent kinase 5, CDK5
glucokinase (hexokinase 4, maturity onset diabetes of the young 2), GCK
nuclear receptor binding protein, NRBP
phosphatidylinositol 4-kinase, catalytic, beta polypeptide, PIK4CB
ribosomal protein S6 kinase, 70kDa, polypeptide 2, RPS6KB2
mitogen-activated protein kinase 14, MAPK14
galactokinase 2, GALK2
calmodulin 3 (phosphorylase kinase, delta), CALM3
PCTAIRE protein kinase 1, PCTK1
cyclin-dependent kinase 2, CDK2
galactokinase 1, GALK1
non-metastatic cells 3, protein expressed in, NME3
glycogen synthase kinase 3 beta, GSK3B
megakaryocyte-associated tyrosine kinase, MATK
mitogen-activated protein kinase 12, MAPK12
activin A receptor, type IB, ACVR1B
pyridoxal (pyridoxine, vitamin B6) kinase, PDXK
non-metastatic cells 2, protein (NM23B) expressed in, NME2
N-acetylglucosamine kinase, NAGK
v-raf murine sarcoma 3611 viral oncogene homolog 1, ARAF1
serine/threonine kinase 16, STK16
phosphofructokinase, platelet, PFKP
phosphorylase kinase, gamma 2 (testis), PHKG2
CDC-like kinase 3, CLK3
phosphoenolpyruvate carboxykinase 2 (mitochondrial), PCK2
deoxyguanosine kinase, DGUOK
adenylate kinase 1, AK1
RIO kinase 2 (yeast), FLJ11159
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa, NDUFA10
cyclin-dependent kinase 9 (CDC2-related kinase), CDK9
DKFZP586B1621 protein, DKFZP586B1621
mitogen-activated protein kinase kinase kinase 11, MAP3K11
PCTAIRE protein kinase 3, PCTK3
p21(CDKN1A)-activated kinase 4, PAK4
3'-phosphoadenosine 5'-phosphosulfate synthase 1, PAPSS1
TP53 regulating kinase, C20orf64
protein kinase, interferon-inducible double stranded RNA dependent, PRKR
pyruvate dehydrogenase kinase, isoenzyme 3, PDK3
mevalonate kinase (mevalonic aciduria), MVK
mitogen-activated protein kinase kinase kinase kinase 2, MAP4K2
sterile alpha motif and leucine zipper containing kinase AZK, ZAK
myosin, light polypeptide kinase, MYLK
EPH receptor B2, EPHB2
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase, GNE
pyruvate kinase, liver and RBC, PKLR
glycerol kinase 2, GK2
bone morphogenetic protein receptor, type IA, BMPR1A
tripartite motif-containing 28, TRIM28
hypothetical protein MGC16169, MGC16169
SNF1-like kinase, SNF1LK
activin A receptor, type IC, ACVR1C
serine/threonine kinase 25 (STE20 homolog, yeast), STK25
tyrosine kinase, non-receptor, 1, TNK1
adenylate kinase 7, AK7
maternal embryonic leucine zipper kinase, MELK
PDLIM1 interacting kinase 1 like, PDIK1L
G protein-coupled receptor kinase 6, GRK6
microtubule associated serine/threonine kinase-like, FLJ14813
ataxia telangiectasia mutated (includes complementation groups A, C and D), ATM
tribbles homolog 1 (Drosophila), TRIB1
xylulokinase homolog (H. influenzae), XYLB
cyclin-dependent kinase (CDC2-like) 10, CDK10
p21 (CDKN1A)-activated kinase 2, PAK2
cyclin-dependent kinase-like 4, CDKL4
aarF domain containing kinase 1, ADCK1
cyclin-dependent kinase 3, CDK3
activin A receptor, type IIB, ACVR2B
hypothetical protein FLJ25006, FLJ25006
unc-51-like kinase 3 (C. elegans), ULK3
aortic preferentially expressed gene 1, APEG1
PAS domain containing serine/threonine kinase, PASK
hexokinase domain containing 1, HKDC1
phosphorylase kinase, alpha 1 (muscle), PHKA1
phosphoinositide-3-kinase, catalytic, delta polypeptide, PIK3CD
v-abl Abelson murine leukemia viral oncogene homolog 1, ABL1
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5), MPP5
PTK7 protein tyrosine kinase 7, PTK7
SNF related kinase, SNRK
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A, DYRK1A
cyclin-dependent kinase-like 5, CDKL5
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent), RNASEL
protein kinase C, epsilon, PRKCE
endoplasmic reticulum to nucleus signalling 1, ERN1
adrenergic, beta, receptor kinase 2, ADRBK2
v-akt murine thymoma viral oncogene homolog 2, AKT2
chaperone, ABC1 activity of bc1 complex like (S. pombe), CABC1
NIMA (never in mitosis gene a)- related kinase 11, NEK11
male germ cell-associated kinase, MAK
mitogen-activated protein kinase kinase kinase 2, MAP3K2
zeta-chain (TCR) associated protein kinase 70kDa, ZAP70
NAD kinase, NADK
phosphatidylinositol-4-phosphate 5-kinase, type II, beta, PIP5K2B
interleukin-1 receptor-associated kinase 2, IRAK2
CDC7 cell division cycle 7 (S. cerevisiae), CDC7
G protein-coupled receptor kinase 1, GRK1
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2), MPP2
activin A receptor, type IC, ACVR1C
intestinal cell (MAK-like) kinase, ICK
mitogen-activated protein kinase kinase kinase 3, MAP3K3
serine/threonine kinase 40, STK40
serine/threonine/tyrosine kinase 1, STYK1
renal tumor antigen, RAGE
p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast), PAK1
p21 (CDKN1A)-activated kinase 3, PAK3
FYN oncogene related to SRC, FGR, YES, FYN
v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene), ABL2
ribosomal protein S6 kinase, 90kDa, polypeptide 5, RPS6KA5
insulin receptor-related receptor, INSRR
neurotrophic tyrosine kinase, receptor, type 2, NTRK2
EPH receptor A1, EPHA1
serine/threonine kinase 4, STK4
STE20-like kinase (yeast), SLK
cell division cycle 2-like 1 (PITSLRE proteins), CDC2L1
protein kinase C, alpha, PRKCA
leucine-rich repeat kinase 1, LRRK1
muscle, skeletal, receptor tyrosine kinase, MUSK
neurotrophic tyrosine kinase, receptor, type 3, NTRK3
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian), ERBB3
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian), ERBB2
SFRS protein kinase 2, SRPK2
BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast), BUB1B
PTK2B protein tyrosine kinase 2 beta, PTK2B
homeodomain interacting protein kinase 4, HIPK4
colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog, CSF1R
polo-like kinase 4
interleukin-1 receptor-associated kinase 4, IRAK4
calcium/calmodulin-dependent protein kinase (CaM kinase) II beta, CAMK2B
mitogen-activated protein kinase kinase kinase 14, MAP3K14
SFRS protein kinase 1, SRPK1
interleukin-1 receptor-associated kinase 1, IRAK1
p21(CDKN1A)-activated kinase 7, PAK7
hexokinase 3 (white cell), HK3
phosphoinositide-3-kinase, class 3, PIK3C3
mitogen-activated protein kinase kinase 1, MAP2K1
serine/threonine kinase 3 (STE20 homolog, yeast), STK3
lymphocyte-specific protein tyrosine kinase, LCK
homeodomain interacting protein kinase 3, HIPK3
mitogen-activated protein kinase-activated protein kinase 2, MAPKAPK2
calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha, CAMK2A
mitogen-activated protein kinase 7, MAPK7
Fas-activated serine/threonine kinase, FASTK
mitogen-activated protein kinase 1, MAPK1
casein kinase 1, gamma 2, CSNK1G2
anti-Mullerian hormone receptor, type II, AMHR2
protein kinase LYK5, LYK5
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog, FGR
serine/threonine kinase 19, STK19
Mst3 and SOK1-related kinase, RP6-213H19.1
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B, DYRK1B
protein kinase, membrane associated tyrosine/threonine 1, PKMYT1
mitogen-activated protein kinase kinase 2, MAP2K2
mitogen-activated protein kinase kinase 5, MAP2K5
uridine-cytidine kinase 2, UCK2
riboflavin kinase, RFK
ethanolamine kinase 1, ETNK1
hypothetical protein FLJ10986, FLJ10986
Coenzyme A synthase, COASY
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa, TAF9
inositol hexaphosphate kinase 2, IHPK2
adenylate kinase 5, AK5
uridine-cytidine kinase 1, UCK1
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, PIP5K1C
receptor interacting protein kinase 5, RIPK5
inositol hexaphosphate kinase 3, IHPK3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1, PFKFB1
phosphorylase kinase, alpha 2 (liver), PHKA2
PTK2 protein tyrosine kinase 2, PTK2
fucokinase, FUK
AXL receptor tyrosine kinase, AXL
NIMA (never in mitosis gene a)-related kinase 3, NEK3
TANK-binding kinase 1, TBK1
glycogen synthase kinase 3 alpha, GSK3A
calcium/calmodulin-dependent protein kinase (CaM kinase) II delta, CAMK2D
BMP2 inducible kinase, BMP2K
bromodomain containing 2, BRD2
germ cell associated 2 (haspin), GSG2
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, KIT
diacylglycerol kinase, theta 110kDa, DGKQ
mitogen-activated protein kinase kinase kinase kinase 3, MAP4K3
SCY1-like 1 (S. cerevisiae), SCYL1
EPH receptor B3, EPHB3
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B), NPR2
chromosome 9 open reading frame 96, C9orf96
PTK6 protein tyrosine kinase 6, PTK6
myosin light chain kinase 2, skeletal muscle, MYLK2
inositol polyphosphate multikinase, IPMK
serine/threonine kinase 23, STK23
activin A receptor, type IIA, ACVR2A
EPH receptor A10, EPHA10
insulin receptor, INSR
platelet-derived growth factor receptor, alpha polypeptide, PDGFRA
LATS, large tumor suppressor, homolog 1 (Drosophila), LATS1
v-raf murine sarcoma viral oncogene homolog B1, BRAF
testis expressed sequence 14, TEX14
spleen tyrosine kinase, SYK
mitogen-activated protein kinase kinase kinase 5, MAP3K5
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3), MPP3
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3, DYRK3
BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast), BUB1
testis-specific kinase 2, TESK2
membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6), MPP6
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A), NPR1
receptor-interacting serine-threonine kinase 3, RIPK3
bone morphogenetic protein receptor, type II (serine/threonine kinase), BMPR2
serine/threonine kinase 31, STK31
glycogen synthase kinase 3 alpha, GSK3A
PRP4 pre-mRNA processing factor 4 homolog B (yeast), PRPF4B
mitogen-activated protein kinase-activated protein kinase 5, MAPKAPK5
EPH receptor B4, EPHB4
misshapen-like kinase 1 (zebrafish), MINK1
3'-phosphoadenosine 5'-phosphosulfate synthase 2, PAPSS2
tight junction protein 2 (zona occludens 2), TJP2
interleukin-1 receptor-associated kinase 3, IRAK3
cyclin-dependent kinase-like 3, CDKL3
diacylglycerol kinase, eta, DGKH
MAP kinase interacting serine/threonine kinase 1, MKNK1
EPH receptor A3, EPHA3
inositol hexaphosphate kinase 1, IHPK1
mitogen-activated protein kinase kinase 7, MAP2K7
hexokinase 2, HK2
chromosome 6 open reading frame 199, C6orf199
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2, ALS2CR2
serine/threonine kinase 32B, STK32B
protein kinase N3, PKN3
ethanolamine kinase 2, ETNK2
TTK protein kinase, TTK
protein kinase C, gamma, PRKCG
pim-2 oncogene, PIM2
non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase), NME5
protein kinase C, beta 1, PRKCB1
chromosome 1 open reading frame 57, C1orf57
membrane associated guanylate kinase, WW and PDZ domain containing 1, MAGI1
mitogen-activated protein kinase kinase kinase kinase 3, MAP4K3
TNNI3 interacting kinase, TNNI3K
MAP/microtubule affinity-regulating kinase 4, MARK4
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4), MPP4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1, PFKFB1
dystrophia myotonica-protein kinase, DMPK
choline kinase alpha, CHKA
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 7, ALS2CR7
death-associated protein kinase 2, DAPK2
cyclin-dependent kinase-like 1 (CDC2-related kinase), CDKL1
U2AF homology motif (UHM) kinase 1, UHMK1
serine/threonine kinase 23, STK23
Cdc2-related kinase, arginine/serine-rich, CRKRS
death-associated protein kinase 1, DAPK1
met proto-oncogene (hepatocyte growth factor receptor), MET
KIAA2002 protein, KIAA2002
phosphoinositide-3-kinase, regulatory subunit 4, p150, PIK3R4
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor), FLT1
nemo like kinase, NLK
aurora kinase C, AURKC
transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kDa), TGFBR1
cell division cycle 2-like 6 (CDK8-like), CDC2L6
adenylate kinase 3-like 2, AK3L2
cyclin-dependent kinase-like 2 (CDC2-related kinase), CDKL2
receptor interacting protein kinase 5, RIPK5
KIAA0999 protein, KIAA0999
protein kinase D3, PRKD3
protein kinase D2, PRKD2
kinase suppressor of ras 1, KSR1
Janus kinase 3 (a protein tyrosine kinase, leukocyte), JAK3
mitogen-activated protein kinase kinase kinase kinase 1, MAP4K1
discoidin domain receptor family, member 2, DDR2
alpha-kinase 1, ALPK1
fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94), FER
discs, large homolog 3 (neuroendocrine-dlg, Drosophila), DLG3
diacylglycerol kinase, beta 90kDa, DGKB
EPH receptor B1, EPHB1
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, IKBKB
tousled-like kinase 2, TLK2
bromodomain containing 3, BRD3
calcium/calmodulin-dependent serine protein kinase (MAGUK family), CASK
receptor (TNFRSF)-interacting serine-threonine kinase 1, RIPK1
PX domain containing serine/threonine kinase, PXK
mitogen-activated protein kinase 4, MAPK4
testis-specific kinase 2, TESK2
EPH receptor A6, EPHA6
LIM domain kinase 2, LIMK2
inositol 1,3,4-triphosphate 5/6 kinase, ITPK1
v-raf-1 murine leukemia viral oncogene homolog 1, RAF1
mitogen-activated protein kinase kinase kinase 7, MAP3K7
phosphatidylinositol 4-kinase, catalytic, alpha polypeptide, PIK4CA
BMX non-receptor tyrosine kinase, BMX
lymphocyte-specific protein tyrosine kinase, LCK
adenylate kinase 3 like 1, AK3L1
hypothetical protein FLJ20574, FLJ20574
pantothenate kinase 3, PANK3
serum/glucocorticoid regulated kinase-like, SGKL
carbohydrate kinase-like, CARKL
non-metastatic cells 1, protein (NM23A) expressed in, NME1
aurora kinase B, STK12
membrane protein, palmitoylated 1, 55kDa, MPP1
calmodulin 1 (phosphorylase kinase, delta), CALM1
serum/glucocorticoid regulated kinase, SGK
ribosomal protein S6 kinase, 90kDa, polypeptide 2, RPS6KA2
serine/threonine kinase 17b (apoptosis-inducing), STK17B
phosphofructokinase, muscle, PFKM
serine/threonine kinase 17a (apoptosis-inducing), STK17A
v-akt murine thymoma viral oncogene homolog 1, AKT1
non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase), NME6
CHK2 checkpoint homolog (S. pombe), CHEK2
CHK1 checkpoint homolog (S. pombe), CHEK1
phosphatidylinositol-4-phosphate 5-kinase, type II, alpha, PIP5K2A
IL2-inducible T-cell kinase, ITK
pim-1 oncogene, PIM1
phosphatidylinositol-4-phosphate 5-kinase, type I, beta, PIP5K1B
Bruton agammaglobulinemia tyrosine kinase, BTK
deoxycytidine kinase, DCK
diacylglycerol kinase, gamma 90kDa, DGKG
serine/threonine kinase 3 (STE20 homolog, yeast), STK3
activin A receptor, type I, ACVR1
adenylate kinase 3, AK3
LIM domain kinase 1, LIMK1
ribosomal protein S6 kinase, 90kDa, polypeptide 3, RPS6KA3
glycerol kinase, GK
serine/threonine kinase 38, STK38
casein kinase 1, gamma 2, CSNK1G2
phosphoribosyl pyrophosphate synthetase 2, PRPS2
polo-like kinase 3
protein kinase, cGMP-dependent, type I, PRKG1
serine/threonine kinase 10, STK10
vaccinia related kinase 2, VRK2
hypothetical protein FLJ10842, FLJ10842
phosphatidylinositol-4-phosphate 5-kinase, type II, gamma, FLJ22055
p21(CDKN1A)-activated kinase 6, PAK6
phosphoinositide-3-kinase, catalytic, alpha polypeptide, PIK3CA
phosphoinositide-3-kinase, catalytic, beta polypeptide, PIK3CB
CDC-like kinase 2, CLK2
death-associated protein kinase 3, DAPK3
calcium/calmodulin-dependent protein kinase IG, CAMK1G
diacylglycerol kinase, alpha 80kDa, DGKA
MAP kinase-interacting serine/threonine kinase 2, MKNK2
mitogen-activated protein kinase kinase kinase 8, MAP3K8
calcium/calmodulin-dependent protein kinase I, CAMK1
cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase), CDK7
UMP-CMP kinase, UMP-CMPK
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4, PFKFB4
ribosomal protein S6 kinase, 90kDa, polypeptide 6, RPS6KA6
c-src tyrosine kinase, CSK
protein kinase, AMP-activated, alpha 1 catalytic subunit, PRKAA1
ezrin-binding partner PACE-1, PACE-1
unc-51-like kinase 2 (C. elegans), ULK2
protein kinase C-like 2, PRKCL2
adenylate kinase 2, AK2
B lymphoid tyrosine kinase, BLK
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon, IKBKE
calcium/calmodulin-dependent protein kinase ID, CKLiK
RIO kinase 3 (yeast), SUDD
CDC-like kinase 4, CLK4
bone morphogenetic protein receptor, type IB, BMPR1B
TXK tyrosine kinase, TXK
discs, large homolog 5 (Drosophila), DLG5
casein kinase 1, alpha 1, CSNK1A1
T-LAK cell-originated protein kinase, TOPK
casein kinase 2, alpha 1 polypeptide, CSNK2A1
uridine kinase-like 1, URKL1
PCTAIRE protein kinase 2, PCTK2
casein kinase 2, alpha prime polypeptide, CSNK2A2
activin A receptor type II-like 1, ACVRL1
creatine kinase, mitochondrial 2 (sarcomeric), CKMT2
ribosomal protein S6 kinase, 90kDa, polypeptide 1, RPS6KA1
v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1, YES1
ribosomal protein S6 kinase, 70kDa, polypeptide 1, RPS6KB1
serine/threonine kinase 24 (STE20 homolog, yeast), STK24
serine/threonine kinase 22D (spermiogenesis associated), STK22D
choline kinase beta, CHKL
phosphatidylinositol 4-kinase type-II beta, PI4K2B
hypothetical protein FLJ23356, FLJ23356
tec protein tyrosine kinase, TEC
serine/threonine protein kinase SSTK, SSTK
pyruvate dehydrogenase kinase, isoenzyme 1, PDK1
vaccinia related kinase 3, LOC51231
ribokinase, RBSK
pyruvate dehydrogenase kinase, isoenzyme 4, PDK4
3-phosphoinositide dependent protein kinase-1, PDPK1
thiamin pyrophosphokinase 1, TPK1
fructosamine-3-kinase, FN3K
G protein-coupled receptor kinase 5, GPRK5
serum/glucocorticoid regulated kinase 2, SGK2
calcium/calmodulin-dependent protein kinase IV, CAMK4
EphA4, EPHA4
vaccinia related kinase 1, VRK1
likely ortholog of rat SNF1/AMP-activated protein kinase, SNARK
cyclin-dependent kinase 9 (CDC2-related kinase), CDK9
integrin-linked kinase, ILK
NIMA (never in mitosis gene a)-related kinase 2, NEK2
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa, TAF9
fyn-related kinase, FRK
v-raf murine sarcoma 3611 viral oncogene homolog 1, ARAF1
cyclin-dependent kinase 4, CDK4
casein kinase 1, epsilon, CSNK1E
cyclin-dependent kinase 6, CDK6
thymidine kinase 2, mitochondrial, TK2
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma), AKT3
mitogen-activated protein kinase kinase 4, MAP2K4
ataxia telangiectasia and Rad3 related, ATR
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog, LYN
mitogen-activated protein kinase 11, MAPK11
mitogen-activated protein kinase 9, MAPK9
mitogen-activated protein kinase 10, MAPK10
mitogen-activated protein kinase 13, MAPK13
mitogen-activated protein kinase kinase 3, MAP2K3
mitogen-activated protein kinase kinase 6, MAP2K6
mitogen-activated protein kinase 14, MAPK14
mitogen-activated protein kinase kinase kinase 7, MAP3K7
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian), ERBB4
transforming growth factor, beta receptor II (70/80kDa), TGFBR2
PTK9 protein tyrosine kinase 9, PTK9
cyclin-dependent kinase 5, CDK5
Pfu DNA Polymerase
GeneExpresso™ Max Transfection Reagent
PolyExpress™ Tranfection Reagent
GeneExpresso™ Transfection Reagent
GeneExpresso™ 8000 Transfection Reagent
Custom Protein Purification Services using Akta FPLC Systems
Protein Expression using Stable Mammalian Cell Line
Transient Protein Production using HEK 293 Cells
Protein Expression and Purification using Baculovirus Expression System
Protein Expression and Purification using Bacterial Expression System
Recombinant Human Interferon gamma
Recombinant Human Interferon alpha-2b, IFN alpha 2b, (rHuIFN-α2b)
Recombinant Human Interferon alpha-2a, INF alpha 2a, (rHuIFN-α2a)